A retrospective, cohort study analysing long-term impact of the PCV13 infant immunization program on all (outpatient and inpatient) CAP cases in an entire population
Latest Information Update: 17 Jan 2022
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Community-acquired pneumonia; Pneumococcal infections
- Focus Therapeutic Use
Most Recent Events
- 17 Jan 2022 New trial record
- 07 Jan 2022 Results published in the Vaccine